Crestor (or Crestor CR, Inc.) is a prescription drug that helps to reduce your cholesterol level. It is used to treat people with high-intensity exercise like those who have a lot of muscle and fatty deposits. Crestor CR is usually prescribed in a lower dose and should not be taken more than once a day.
Crestor CR is used to treat high-intensity exercise like those who have a lot of muscle and fatty deposits.
Crestor CR is also used to treat people with liver diseases, as it lowers the liver enzymes.Crestor CR is a prescription drug. You should talk to your doctor if you are taking it or not.
Crestor CR is usually taken with a meal. You can take Crestor CR with or without food. You should take it about once per day.
The recommended dosage for Crestor CR is 10 to 20 milligrams.
You should take Crestor CR regularly every day. In the case of Crestor CR being taken as per your doctor’s prescription, you should be aware of how much Crestor CR can be taken every day.
Crestor CR is not a cure for your condition.
You should consult your doctor before taking Crestor CR if you are pregnant, breastfeeding, or have liver problems.
You should nottake Crestor CR if you have:
Crestor CR is also used for people with high cholesterol.
You should talk to your doctor about Crestor CR if you have:
Read more about Crestor.
This is not a complete list of all side effects. If you have concerns, talk to your doctor. They can help you determine if Crestor CR is the right medication for you.
Read more about Crestor (Crestor CR).If you have a prescription for Crestor, you must have one of the following medical history information before you can take it:
This list is not complete. Other drugs, vitamins, and supplements may have different side effects on Crestor (Crestor CR). Ask your doctor about other treatment options for your condition. It is important to talk to your doctor about other treatment options before you take Crestor CR. Your doctor can help determine if Crestor CR is right for you.
If you have questions about Crestor (Crestor CR), talk to your doctor.
April 19, 2012— --The Food and Drug Administration (FDA) announced today that it has approved two additional drugs that treat cholesterol-lowering drugs. These are generic cholesterol-lowering drugs used to treat adults with high cholesterol, such as Lipitor, Crestor, Pfizer's Lipitor XR, and Merck's Merit Systems Protection (MPS) Crestor.
This new label will allow the FDA to continue to advise patients about these medications, but the agency also ordered that it will be updated in the coming weeks. The drug products will be available as a generic version of Pfizer's cholesterol-lowering drug Lipitor, which was launched in the U. S. in January. The drug products are being marketed under the name "Pfizer" to help people save money on their prescriptions.
"Pfizer and Merck are the largest purchasers of Lipitor in the United States and have made significant savings," said Dr. David A. Hirsch, director of the Center for Drug Evaluation and Research at the Cleveland Clinic. "This change is a good move by Pfizer and Merck to continue to provide the best available information on the drugs."
According to the FDA, Pfizer's Lipitor is the only approved drug to treat cholesterol-lowering cholesterol-lowering patients. However, the label for Lipitor, called "HMG-CoA reductase inhibitor," is not the only approved drug for this indication.
A "black box warning" is an added warning that indicates that patients who take the drug, regardless of how well they tolerate it, may experience an increased risk of developing certain serious side effects such as liver injury, heart failure, or kidney failure.
"People with a history of liver disease or who are elderly or who have a history of cardiovascular disease should not take Lipitor. This is because it is not effective for these patients," said Dr. A. G. Brinkman, a professor of pharmacology at the University of California, San Francisco.
As a result of the new label, some of the drugs now being studied are designed to lower LDL cholesterol, a measure of a person's overall health and quality of life. It was not immediately available in the U. on the drug products.
"This is a major change from the use of Lipitor, which was initially developed to treat people who do not have cholesterol," said Dr. M. Hovenson, director of the Center for Drug Evaluation and Research at the Cleveland Clinic.
A study in mice showed that the drug increased the production of the LDL receptor in the liver, which is the enzyme that makes cholesterol. In humans, the results showed that when the body is stimulated to release cholesterol from the liver, the liver can produce more LDL cholesterol than it has already. The results were presented this week at the American Heart Association's American Heart Association Scientific Sessions.
According to the study, the drug is safe and effective for patients with the same cholesterol levels as Lipitor.
"In this study, we did not show that the drug has the same effect on the liver as Lipitor," said Dr. Hovenson. "However, if you take the drug and you can't get enough cholesterol from the liver, then you may be having a harder time getting the right nutrients from the diet."
About Crestor (rosuvastatin calcium) is a prescription medication used to treat high cholesterol in adults and certain other cholesterol-lowering drugs.
According to the FDA, Crestor is the only FDA-approved drug to treat the symptoms of high cholesterol in adults.
The FDA said that Crestor can also be used to lower the risk of certain types of heart disease, such as atrial fibrillation, stroke, and myocardial infarction.
About 40 percent of people with high cholesterol can have heart disease or stroke. It also is effective in preventing these people from having a heart attack or stroke.
The FDA also said that Crestor can be used to reduce the risk of developing Alzheimer's disease and dementia. It is not known whether Crestor will be used for those who already have the disease.
"There are no data on the safety and efficacy of Crestor in people with high risk factors," said Dr. J. Hovenson, director of the Center for Drug Evaluation and Research.
Dr. Nader, M. D.
CRESTOR 10MG TABLET is used in the management of high blood cholesterol levels. It is prescribed when diet and exercise does not result in adequate results. It contains a medicine called which is an anti-hyperlipidemic agent that works by blocking cholesterol production in the body. It also makes your body eliminate lipids particles from the blood.
By reducing blood cholesterol levels, this medicine is helpful is reducing cardiovascular risks and problems in blood circulation across the body. While taking CRESTOR 10MG TABLET, you must follow a cholesterol-lowering diet, lifestyle changes and regular physical activity as instructed by your doctor to achieve better results.
Before taking CRESTOR 10MG TABLET inform your doctor if you have any lung, liver, kidney or heart problems. You must also inform your doctor if you have diabetes, thyroid problems, or a family history of muscle disorders. Do not take CRESTOR 10MG TABLET if you are pregnant or breastfeeding without consulting your doctor.
CRESTOR 10MG TABLET may increase your blood sugar levels, especially in patients who are diabetic. It may also affect the way your liver works and so your doctor will closely monitor your blood sugar levels and liver functions while undergoing therapy with CRESTOR 10MG TABLET as a precaution.
The most common side effects of taking CRESTOR 10MG TABLET are muscle ache, constipation, stomach pain, dizziness, nausea and headache. Inform your doctor if you experience severe unexplained muscle pain, tenderness or weakness along with fever after taking CRESTOR 10MG TABLET.
How should I take CRESTOR 10MG TABLET? CRESTOR 10MG TABLET should be taken with caution. It should be taken only when you experience severe muscle pain, fever or any other side effect while taking this medication. It should be taken with caution in patients with muscle disorders and should be used with special emphasis be it diet or only with extreme caution.Inform your doctor if you have any of these symptoms:
The amount of water for oral consumption is usually reduced with taking CRESTOR 10MG TABLET. You can take CRESTOR 10MG TABLET with or without food but, when needed, may be taken with your meal. You should not drink alcohol while taking CRESTOR 10MG TABLET.
Background:Crestor, a lipase inhibitor, has been associated with a higher incidence of cardiovascular disease, myocardial infarction and stroke than other statins. A retrospective analysis of statin-associated cardiovascular events reported a significant association between low LDL cholesterol and the incidence of all-cause, cardiovascular disease, stroke and MI, including heart attack. To date, there is no clear evidence to support a direct causal relationship between statin use and these outcomes.
Methods:This is a retrospective cohort study using data on statin use at baseline in the United States and compared statin-associated cardiovascular events with a case-control population. The analysis was performed using the Poisson distribution. A total of 6,731 adults aged ≥50 years with at least 1 year of statin use were identified in the study cohort. The study cohort was divided into 1,049 statin-associated cardiovascular events (SCACE) and matched to 1,025 additional controls. A matched cohort was created by adjusting for age and sex using the same propensity score-matched population, as well as the number of statin-associated events per 1000 person-years of use. Baseline characteristics were obtained from the electronic health records of the US population. The primary outcome was the incidence of any cardiovascular event or cardiovascular death or stroke. Secondary outcomes were the incidence of nonfatal myocardial infarction (MI), myocardial infarction and stroke. The analysis was performed using the SAS/SAS V.9.3 statistical package (SAS Institute, Inc., Cary, NC). Secondary outcomes were the incidence of nonfatal MI, myocardial infarction and stroke. The statistical analyses were performed using Stata V.14.2 (Stata Corporation, College Station, TX).
Results:The incidence of any cardiovascular event or cardiovascular death or stroke increased with statin use. The increase was greater in individuals with lower LDL-cholesterol or higher levels of HDL-cholesterol. The hazard ratio for any cardiovascular event or cardiovascular death or stroke was 0.60, 0.59, and 0.61, respectively, in the cohort using statin-associated events versus those without statin-associated events. No statistically significant differences were found in the rate of nonfatal myocardial infarction, MI and stroke. The adjusted hazard ratio for any cardiovascular event or cardiovascular death or stroke was 0.42, 0.45, and 0.30, respectively, in the statin-associated event versus those without statin-associated events. The adjusted hazard ratio for nonfatal MI was 0.42, 0.44, and 0.25, respectively, in the statin-associated event versus those without statin-associated events. The adjusted hazard ratio for any cardiovascular event or cardiovascular death or stroke was 0.40, 0.28, and 0.28, respectively, in the statin-associated event versus those without statin-associated events. The adjusted hazard ratio for nonfatal MI was 0.29, 0.23, and 0.14, respectively, in the statin-associated event versus those without statin-associated events. The adjusted hazard ratio for MI was 0.15, 0.03, and 0.01, respectively, in the statin-associated event versus those without statin-associated events. The adjusted hazard ratio for stroke was 0.07, 0.02, and 0.03, respectively, in the statin-associated event versus those without statin-associated events. The adjusted hazard ratio for nonfatal stroke was 0.13, 0.02, and 0.01, respectively, in the statin-associated event versus those without statin-associated events. The adjusted hazard ratio for MI was 0.14, 0.04, and 0.02, respectively, in the statin-associated event versus those without statin-associated events. The adjusted hazard ratio for nonfatal stroke was 0.11, 0.03, and 0.01, respectively, in the statin-associated event versus those without statin-associated events. The adjusted hazard ratio for MI was 0.10, 0.03, and 0.01, respectively, in the statin-associated event versus those without statin-associated events. The adjusted hazard ratio for stroke was 0.12, 0.01, and 0.03, respectively, in the statin-associated event versus those without statin-associated events. The adjusted hazard ratio for MI was 0.09, 0.04, and 0.
Stade de France Pharmacy